Submitted by Anonymous (not verified) on 20 November 2023 - 13:04
Human medicines European public assessment report (EPAR): Vimizim, elosulfase alfa, Mucopolysaccharidosis IV, Date of authorisation: 27/04/2014, Revision: 13, Status: Authorised
Source: